findmyKOL

Meghan Hession, MD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionSan Mateo, CA · WestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2016Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Meghan Hession is a Dermatology physician. OpenAlex indexes 13 publications with 402 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

402citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
22companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

280 Baldwin Avenue
San Mateo, CA 94409

Telephone

650-344-1121

Provider last certified this registry record 10 Apr 2025.

View the NPPES registry record

Industry payments

22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    33.7%
    Corticosteroid27.2%
    Triamcinolone Acetonide59%Triamcinolone acetonide41%
    Part D + Part B44 patients
    Interleukin-4 Receptor alpha Antagonist6.5%
    Dupixent Pen100%
    Part D<11 patients
  • Anti-infectives

    22.9%
    Azole Antifungal19.8%
    Ketoconazole100%
    Part D32 patients
    Nitroimidazole Antimicrobial3.1%
    Metronidazole100%
    Part D<11 patients
  • Cardiovascular

    16.1%
    Arteriolar Vasodilator9.3%
    Minoxidil100%
    Part D12 patients
    Corticosteroid6.8%
    Fluocinonide100%
    Part D12 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

8 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”